Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological aspects of pre-eclampsia.

C W Redman1

  • 1Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford, UK.

Bailliere'S Clinical Obstetrics and Gynaecology
|September 1, 1992
PubMed
Summary

Pre-eclampsia may stem from the mother's immune system not fully accommodating the fetus, potentially linking it to other pregnancy losses. Further research is needed to clarify its immune origins and two-stage development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HLA-DR is aberrantly expressed at feto-maternal interface in pre-eclampsia.

Journal of reproductive immunology·2018
Same author

Angiogenic factors: potential to change clinical practice in pre-eclampsia?

BJOG : an international journal of obstetrics and gynaecology·2017
Same author

Trophoblast Glycoprotein (TPGB/5T4) in Human Placenta: Expression, Regulation, and Presence in Extracellular Microvesicles and Exosomes.

Reproductive sciences (Thousand Oaks, Calif.)·2017
Same author

Pre-eclampsia: Definitions, paternal contributions and a four stage model.

Pregnancy hypertension·2015
Same author

OS100. Plasma placental growth factor (PLGF) measurement in women presenting with suspected pre-eclampsia: the pelican study.

Pregnancy hypertension·2015
Same author

Isolation of syncytiotrophoblast microvesicles and exosomes and their characterisation by multicolour flow cytometry and fluorescence Nanoparticle Tracking Analysis.

Methods (San Diego, Calif.)·2015

Area of Science:

  • Reproductive Immunology
  • Maternal-Fetal Medicine
  • Pathology

Background:

  • Pre-eclampsia is a placental disorder with an undefined pathogenesis.
  • The maternal syndrome is linked to placental ischemia caused by spiral artery insufficiency.
  • The condition shows a first pregnancy preponderance and partner specificity, suggesting immune involvement.

Purpose of the Study:

  • To hypothesize pre-eclampsia as a two-stage disease.
  • To explore potential immunological etiologies for poor placentation and spiral artery issues.
  • To investigate the role of placental ischemia and maternal endothelial dysfunction in pre-eclampsia.

Main Methods:

  • Review of existing literature on pre-eclampsia pathogenesis.
  • Hypothetical modeling of pre-eclampsia as a two-stage process.
  • Analysis of potential immune interactions between mother and fetus.

Main Results:

  • Pre-eclampsia is proposed as a two-stage disease involving poor placentation and subsequent placental ischemia.
  • Immunological factors may contribute to limited spiral artery size or obstruction (poor placentation).
  • Maternal immune intolerance of the fetal allograft could be implicated.

Conclusions:

  • Pre-eclampsia might be part of a spectrum of pregnancy loss due to inadequate maternal immune accommodation.
  • The second stage involves consequences of placental ischemia, possibly linked to endothelial dysfunction.
  • Further investigation is crucial to resolve uncertainties regarding pre-eclampsia's immunological basis.

Related Experiment Videos